Skip to content

Clinical trials

Active, not recruiting Breast Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Active, not recruiting Country / region: China Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20163
20172
20184
20195
202016
202119
202227
202318
202420
202511
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting136

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca15
Fudan University11
Pfizer10
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University8
Hoffmann-La Roche7
Eli Lilly and Company6
Novartis Pharmaceuticals5
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4
Jiangsu HengRui Medicine Co., Ltd.4
Xijing Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms136
Neoplasm Metastasis8
Ovarian Neoplasms7
Triple Negative Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Endometrial Neoplasms4
Prostatic Neoplasms4
Stomach Neoplasms4
Neoplasms3

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.